Changes in survival in de novo metastatic cancer in an era of new medicines.

Marianne Luyendijk,Otto Visser,Hedwig M Blommestein,Ignace H J T de Hingh,Frank J P Hoebers,Agnes Jager,Gabe S Sonke,Elisabeth G E de Vries,Carin A Uyl-de Groot,Sabine Siesling

Journal of the National Cancer Institute（2023）

引用 4|浏览11

暂无评分

摘要

Over 30 years, the survival of patients with de novo M1 disease modestly and unevenly increased among cancers. Metastatic cancer still remains a very lethal disease. Next to better treatment options, we call for better preventive measures and early detection to reduce the incidence of metastatic disease.

查看译文

关键词

metastatic cancer,de novo

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要